One-year outcomes for da Vinci single port robot for transoral robotic surgery.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 32190942.
- Also identified by DOI 10.1002/hed.26143.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The da Vinci single-port (SP) robot is a new instrument for transoral robotic surgery (TORS) in oropharyngeal cancers (OPSCCs). We describe one-year SP surgical outcomes and compare them to da Vinci Si outcomes. Retrospective cohort study at a high-volume TORS center. Consecutive patients undergoing TORS SP procedures from 10/2018 to 09/2019 were included. SP OPSCC outcomes were compared to a historical cohort of Si OPSCC patients. t tests were used to compare continuous variables; χ<sup>2</sup> or Wilcoxon rank-sum tests were used to compare nonparametric categorical variables. Seventy-eight patients underwent SP TORS. The bleed rate was 5.1%, mortality rate was 2.6%, and conversion rate was 0%. Compared to the Si cohort, OPSCC patients undergoing TORS SP procedures saw no significant differences in operative time or post-TORS bleeds (P > .05). The SP is a comparably safe surgical instrument. Overall learning curve for the SP was rapid among experienced TORS surgeons.
Medical subject headings
- Oropharyngeal Neoplasms
- Robotic Surgical Procedures
- Robotics